| |
|
|
|
|
|
|
|||
|
Blood, 1 September 2008, Vol. 112, No. 5, pp. 1620-1627. Prepublished online as a Blood First Edition Paper on June 12, 2008; DOI 10.1182/blood-2008-02-137455.
Submitted February 5, 2008
Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari, Italy * Corresponding author; email: d.sansonno{at}dimo.uniba.it.
Chemokine CXCL13, also known as BCA-1 (B-cell attracting chemokine-1) or BLC (B-lymphocyte chemoattractant), is a major regulator of B cell trafficking. Hepatitis C virus (HCV) infection may be associated with B cell dysfunction and lymphoproliferative disorders, including mixed cryoglobulinemia (MC).
This study evaluates circulating levels of CXCL13 protein and specific mRNA expression in chronically HCV-infected patients with and without MC.
Compared with healthy controls and HCV-infected patients without MC, CXCL13 serum levels were significantly higher in MC patients. The highest CXCL13 levels strongly correlated with active cutaneous vasculitis. CXCL13 gene expression in portal tracts, isolated from liver biopsy tissues with laser capture microdissection, showed enhanced levels of specific mRNA in MC patients with active cutaneous vasculitis. Specific CXCL13 gene mRNA expression was also up-regulated in skin tissue of these patients. These findings paralleled specific deposits of CXCL13 protein both in the liver and in the skin.
Our results indicate that up-regulation of CXCL13 gene expression is a distinctive feature of HCV-infected patients. Higher levels of this chemokine in the liver as well as in the skin of patients with active MC vasculitis suggest a possible interrelation between these biologic compartments.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2008 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||